Psychoanalysis and dermatology: this Sigourney Award Winner is bridging the 2 specialties.
How can digital therapeutics overcome barriers to psychiatric treatment in forensic settings?
The Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.
Session at the 2023 American Psychiatric Association Annual Meeting shares insights on REMS for psychiatric medications.
Evidence indicates that children and adolescents with ADHD have a more than 4-fold increased risk of schizophrenia spectrum and other psychotic disorders in adulthood compared with the general population.
How can you best discuss long-acting injectable options with your patients living with schizophrenia?
Women should be provided with multiple options for treatment if they decide to engage in mental health care during this critical period.
Palliative psychiatry takes a dangerous turn when discussions lead to advocacy for assisted suicide policies for mental illness.
Joining together to discuss psychosis, 3 British experts discuss various ways to respond to and help people who have experienced both trauma and psychosis.
Thanks to a recent Sigourney Award, this association is achieving well-deserved recognition.
Want to stay in the loop on the latest novel neuroplastogen for major depressive disorder, DLX-001? Check out this update.
Perinatal mood and anxiety disorders affect 1 in 5 of perinatal individuals who are pregnant or up to 1 year postpartum. Over the past 2 decades, the US has seen an alarming rise in these disorders.
Does anxiety justify an exemption from vaccine mandates among health care workers?
Postpartum psychosis has a complicated presentation and is often misdiagnosed or missed in patients.
Here’s how we can help improve quality of sleep in both our patients and ourselves.
There is no accurate profile of who will become a school shooter, so mental health clinicians should react as they would with any patient threatening violence: inquire, gain collateral data, assess, and respond.
Beyond the COVID-19-driven shock, we must develop a resilient future in an increasingly uncertain world.
This article was developed and sponsored in collaboration with Neurocrine Biosciences, Inc. Amy LaCouture, RN, BSN, PMHNP-BC and Linda Trinh, DNP, MPH, FNP-C, PMHNP-BC have been compensated by Neurocrine Biosciences, Inc. to author this article and share their perspectives.
During National Men’s Health Month, take time to consider the unique mental health needs of male patients.
In this journal club, a medical student and an addiction psychiatrist review a thematic analysis of successful prevention efforts in states with declining rates of opioid-related overdose deaths.
Perinatal mood and anxiety disorders affect 1 in 5 of perinatal individuals who are pregnant or up to 1 year postpartum. Over the past 2 decades, the US has seen an alarming rise in these disorders.
Research using data from the All of Us Research Program seeks to solve the mystery of what makes medications work for some and not others.
In this CME article, learn more about how to assess the impact of alcohol and cannabis use on anxiety treatment outcomes, recognizing potential adverse effects and interactions.
"Cumulatively, the findings of such reports have led to a concerted effort to encourage physicians to monitor patients for manic symptoms on initiation, reintroduction, and dose modulation of corticosteroid therapy."
The pandemic changed the way individuals think and caused adjustments in our worldviews. How is that impacting our decision-making ability?
A look at the unique challenges of working with powerful and influential clients and strategies for success.
Schizophrenia is one of the most recognized yet least understood chronic brain disorders.